Inventor
ALTMAN ELLIOT
US25 patents
⚠️ This page may combine multiple inventors who share the name “ALTMAN ELLIOT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRINITY THERAPEUTICS INC
6 patentsUS7786258B2Aug 31, 2010
Methods for inhibiting immune complex formation in a subject
TRINITY THERAPEUTICS INC4 citations71
US7714104B2May 11, 2010
Methods for inhibiting immune complex formation in a subject
TRINITY THERAPEUTICS INC7 citations71
US9447145B2Sep 20, 2016
Compositions for inhibiting immune complex formation in a subject
TRINITY THERAPEUTICS INC1 citations60
US8362202B2Jan 29, 2013
Methods for inhibiting immune complex formation in a subject
TRINITY THERAPEUTICS INC2 citations60
US10179803B2Jan 15, 2019
Methods for inhibiting immune complex formation in a subject
TRINITY THERAPEUTICS INC0 citations50
US7584059B2Sep 1, 2009
Inhibition of immune complex formation
TRINITY THERAPEUTICS INC0 citations50
UNIV GEORGIA RES FOUND
5 patentsUS6455284B1Sep 24, 2002
Metabolically engineered E. coli for enhanced production of oxaloacetate-derived biochemicals
UNIV GEORGIA RES FOUND164 citations98
US7365162B2Apr 29, 2008
Stabilized bioactive peptides and methods of identification, synthesis, and use
UNIV GEORGIA RES FOUND16 citations92
US7122516B2Oct 17, 2006
Stabilized bioactive peptides and methods of identification, synthesis and use
UNIV GEORGIA RES FOUND18 citations92
US6818611B1Nov 16, 2004
Stabilized bioactive peptides and methods of identification, synthesis and use
UNIV GEORGIA RES FOUND41 citations92
US7601511B2Oct 13, 2009
Biotin-facilitated transport in gram negative bacteria
UNIV GEORGIA RES FOUND0 citations42
EITEMAN MARK A
3 patentsUS8652825B2Feb 18, 2014
Microbial production of pyruvate and other metabolites
EITEMAN MARK A4 citations70
US8551758B2Oct 8, 2013
Substrate-selective co-fermentation process
EITEMAN MARK A2 citations60
US8278076B2Oct 2, 2012
Microbial production of pyruvate and pyruvate derivatives
EITEMAN MARK A3 citations60
MIDDLE TENNESSEE STATE UNIV
3 patentsUS10993920B2May 4, 2021
2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeutic
MIDDLE TENNESSEE STATE UNIV0 citations61
US11980648B2May 14, 2024
Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit alpha herpesvirus
MIDDLE TENNESSEE STATE UNIV0 citations57
US11007169B2May 18, 2021
Cis-gnetin H and trans-gnetin H as therapeutic agents
MIDDLE TENNESSEE STATE UNIV0 citations55